Skip to main content
. 2019 Apr 15;11:3253–3264. doi: 10.2147/CMAR.S193793

Figure 5.

Figure 5

The interaction between CDKN3 and RAD51 in ESCA. (AB) CDKN3-regulated cisplatin-induced γH2AX foci (A) and quantitative results (B) in ESCA. Scale bar=5 μm. (C) CDKN3 knockdown regulated cisplatin chemoresistance-related proteins. (D) Correlation between CDKN3 and RAD51 mRNA expression in TCGA ESCA dataset. (EF) Interaction between endogenous CDKN3 and RAD51 in EC109R (E) and OE19R (F) cell lines by Co‑IP. ***P<0.001.

Abbreviations: EC109R, cisplatin-resistant EC109 cell line; OE19R, cisplatin-resistant OE19 cell line; NC, negative control; shCDKN3, cells transfected with shCDKN3 plasmid; RSEM, RNA-Seq by Expectation-Maximization.